COMMUNIQUÉS West-GlobeNewswire

Nexalin Technology Secures USPTO Patent for Deep Intracranial Frequency Stimulation (DIFS™) Technology in Treating Substance Use Disorders

14/04/2025 - 18:30

Patent Approval Reinforces Nexalin’s Leadership in Non-Invasive Brain Stimulation for Addiction Treatment HOUSTON, TX, April 14, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “ [...]

AB Science receives notice of allowance for Unites States patent covering masitinib until 2040 in the treatment of sickle cell disease

14/04/2025 - 18:02

PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR UNITED STATES PATENT COVERING MASITINIB UNTIL 2040 IN THE TREATMENT OF SICKLE CELL DISEASE Paris, April 14, 2025, 6pm CET AB Science SA (Euronext - FR0010557264 [...]

AB Science reçoit un avis d’acceptation pour le brevet américain courant jusqu’en 2040 le masitinib dans le traitement de la drépanocytose

14/04/2025 - 18:02

COMMUNIQUE DE PRESSE AB SCIENCE REÇOIT UN AVIS D'ACCEPTATION POUR LE BREVET AMERICAIN COUVRANT JUSQU'EN 2040 LE MASITINIB DANS LE TRAITEMENT DE LA DREPANOCYTOSE Paris, 14 avril 2025, 18h AB Science SA (Euronext - [...]

Ipsen - March 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital

14/04/2025 - 18:00

Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation [...]

Ipsen - Mars 2025 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

14/04/2025 - 18:00

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (conformément à l’article L.233-8 II du Code de commerce et à l’article 223-16 du Règlement Général de l’ [...]

Cara Therapeutics Announces 1-for-3 Reverse Stock Split in Connection with the Proposed Merger with Tvardi Therapeutics

14/04/2025 - 17:50

STAMFORD, Conn., April 14, 2025 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA) (the “Company”), today announced that its Board of Directors (the “Board”) has approved a 1-for-3 reverse stock split of its [...]

Valneva Receives First Marketing Authorization for IXCHIQ® in a Chikungunya Endemic Country

14/04/2025 - 17:45

Saint Herblain (France), April 14, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company today announced that the Brazilian Health Regulatory Agency (ANVISA) has granted marketing [...]

Valneva reçoit la première autorisation de mise sur le marché pour IXCHIQ® dans un pays où le chikungunya est endémique

14/04/2025 - 17:45

Saint Herblain (France), le 14 avril 2025 - Valneva SE (Nasdaq : VALN ; Euronext Paris : VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que l'agence de santé brésilienne (ANVISA) a accordé l' [...]

BioPorto A/S initiates a private placement of up to 25,000,000 new shares at market price. The Board of Directors has received advance indications for the full offering which is expected to raise proceeds of DKK 33.5 million.

14/04/2025 - 16:55

April 14, 2025 Announcement no. 10 THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR ANY [...]

Prostadine Drops Reviews [We Tested It] Read Ingredients, Side Effects for Urinary System

14/04/2025 - 16:24

ST. PETERSBURG, Fla., April 14, 2025 (GLOBE NEWSWIRE) -- Prostadine The Natural Solution for Prostate Health - As men age, prostate health often becomes a significant concern. The prostate, a small, walnut-sized gland [...]

[Corrected] Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US

14/04/2025 - 16:00

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules – corrected: reference to date of product launch in Europe removed; link to “Important Safety Information” updated Company aims to accelerate [...]

Positron Corporation Secures Agreement to Sell Four PET-CT Scanners

14/04/2025 - 15:51

Niagara Falls, NY, April 14, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company specializing in PET and PET-CT imaging systems and [...]

Free Oral Cancer Screenings in Honor of Oral, Head and Neck Cancer Awareness Month

14/04/2025 - 15:00

26 USOSM Surgeon Partners to Participate Across Seven States IRVING, Texas, April 14, 2025 (GLOBE NEWSWIRE) -- In honor of Oral, Head and Neck Cancer Awareness Month, 26 U.S. Oral Surgery Management surgeon partners in [...]

VIVUS Announces Enrollment of First Patient in Phase 2 Clinical Trial Assessing Ethanol-Free Carmustine as a Component of High-Dose Chemotherapy Prior to Transplant in Patients with Hodgkin or Non-Hodgkin Lymphoma

14/04/2025 - 15:00

— Innovative ethanol-free formulation intended to provide improved safety and advance care for patients undergoing high-dose conditioning therapy prior to autologous hematopoietic cell transplantation (AHCT) — First [...]

NeuroOne® OneRF® Technology Success Story Featured on Fox News

14/04/2025 - 15:00

Pediatric Patient Treated with OneRF ® Ablation System Goes From Up to 10 Nightly Seizures to Zero EDEN PRAIRIE, Minn., April 14, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (" [...]

Regional Health Properties Reports Fourth Quarter & Full Year 2024 Financial Results

14/04/2025 - 15:00

ATLANTA, GA, April 14, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (the “Company”, “Regional”, “we”, “us” or “our”) (OTCQB: RHEP) (OTCQB: RHEPB) (OTCQB: RHEPA), a self-managed healthcare real estate [...]

Verano Announces Promotion and Appointment of Richard Tarapchak as Chief Financial Officer

14/04/2025 - 14:55

Tarapchak brings more than 30 years of accounting and finance expertise to the role CHICAGO, April 14, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading [...]

Transactions in Connection with Share Buy-back Program

14/04/2025 - 14:42

Company Announcement COPENHAGEN, Denmark; April 14, 2025 – Genmab A/S (Nasdaq: GMAB). On March 25, 2025, Genmab announced the initiation of a share buy-back program to repurchase up to 2.2 million shares to reduce [...]

UPDATE -- Relmada Therapeutics To Present NDV-01 Data at AUA2025

14/04/2025 - 14:41

Data to be presented on Monday, April 28, 2025 CORAL GABLES, Fla., April 14, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada”, “the Company”), a clinical-stage biotechnology company, today [...]